Related Experiment Videos
Inclusion body myositis presenting with isolated erector spinae paresis
1Department of Neurology, University of Heidelberg, Germany.
Neurology
|May 1, 1995
Summary
This study details a 70-year-old patient with inclusion body myositis, a progressive muscle disease. Corticosteroid therapy offered minimal benefit, highlighting challenges in treating this condition.
Area of Science:
- Neurology
- Myology
- Pathology
Background:
- Inclusion body myositis (IBM) is a progressive, degenerative muscle disease affecting adults.
- Characterized by insidious onset of muscle weakness, typically in the quadriceps and forearm extensors.
- Diagnostic challenges include differentiating IBM from other myopathies.
Observation:
- A 70-year-old patient presented with a 4-year history of paravertebral muscle weakness.
- Electrodiagnostic studies showed a mixed neurogenic-myopathic pattern.
- Muscle biopsy revealed atrophic fibers with rimmed vacuoles.
Findings:
- Electron microscopy identified characteristic 16 nm cytoplasmic and intranuclear filaments, confirming inclusion body myositis.
- Corticosteroid therapy resulted in only mild and transient symptomatic improvement.
- Disease progression was observed over a 10-month follow-up period.
Implications:
- This case highlights the diagnostic features of inclusion body myositis, including electrodiagnostic and histopathological findings.
- The limited efficacy of corticosteroids underscores the need for novel therapeutic strategies for IBM.
- Understanding disease progression is crucial for patient management and future clinical trial design.